Global Ocular Drug Delivery Technology Market Trends, Analysis, Growth, and Forecast: 2018 to 2027
MarketResearch.biz delivers in-depth insights on the global ocular drug delivery technology market in its upcoming report titled, “Global Ocular Drug Delivery Technology Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global ocular drug delivery technology market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global ocular drug delivery technology market report has been segmented on the basis of product type, formulation type, application, end user, and region.
Ocular drug delivery technology is used in the treatment of ophthalmic diseases such as cataract, glaucoma, diabetic retinopathy etc. Manufactures are developing novel drug delivery technology which enables long lasting effects and better penetration of therapeutic agents.
Increasing prevalence of ocular diseases such as cataract and glaucoma globally is a major factor contributing to growth of the global ocular drug delivery technology market. In 2017, According to World Health Organization (WHO) data an estimated 253 million people are living with vision impairment, whereas 36 million are blind globally. Moreover, rising awareness about ocular diseases such as glaucoma and cataract globally, coupled with several governments and non-profit organizations providing education and support services, is anticipated to further drive growth of the global drug delivery technology market over the forecast period. In addition, growing geriatric population will in turn create demand for ocular drug delivery technology which is other factor contributing to growth of the global drug delivery technology market.
Lack of eye surgeons is major factors restraining the growth of the global drug delivery technology market over the forecast period.
North America dominates the global drug delivery technology market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of eye diseases in the region. Europe accounts for second-largest revenue share contribution to the global drug delivery technology market, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging markets and increasing number of eye surgeries in the region.
Global ocular drug delivery technology market segmentation, by product type:
- Intraocular Implants
- Hydrogel Systems
- Ocular Inserts
- Others (Punctal plugs, cyclodextrines)
Global ocular drug delivery technology market segmentation, by formulation type:
- Nano suspensions
- Others (Niosomes, dendrimers)
Global ocular drug delivery technology market segmentation, by application:
- Diabetic Retinopathy
- Macular Degeneration
Global ocular drug delivery technology market segmentation, by end user:
- Ambulatory Surgical Centers
- Ophthalmic Clinics
Global ocular drug delivery technology market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Alimera Sciences, Inc.
- Valeant Pharmaceuticals International, Inc.
- Clearside Biomedical, Inc.
- Taiwan Liposome Company, Ltd.
- Novartis AG
- Pfizer Inc.
- Envisia Therapeutics, Inc.
- Graybug Vision Inc.
- Allergan, Plc.
- Ocular Therapeutix, Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!